Source: Annual Congress 2012 - Pulmonary circulation: clinical databases and registries
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Trip, E. Nossent, A. Boonstra, H.J. Bogaard, F. de Man, N. Westerhof, K. Grunberg, A. Vonk-Noordegraaf (Amsterdam, Netherlands). Baseline characteristics of idiopathic PAH patients with severely reduced diffusion capacity. Eur Respir J 2012; 40: Suppl. 56, 370

Member's Comments

No comment yet.

Related content which might interest you: Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses Source: Eur Respir J 2013; 42: 1575-1585 Year: 2013 Air-trapping and decreased diffusion capacity in patients with severe asthma Source: Annual Congress 2012 - Asthma: assessment and treatment Year: 2012 Dynamic pathophysiology in stable COPD patients with severely reduced exercise capacity Source: Annual Congress 2011 - Exercise assessment in different diseases Year: 2011 Does the questionnaire “human activity profile” assess functional capacity in patients with idiopathic pulmonary fibrosis? Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia Year: 2021 Reduced exercise capacity and impaired pulmonary function in patients with scleroderma Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease Year: 2010 Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension Source: Eur Respir J, 55 (6) 2000041; 10.1183/13993003.00041-2020 Year: 2020 Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Relationship between exercise tolerance and spirometric data in a group of patients affected by idiopathic dilated cardiomyopathy Source: Eur Respir J 2001; 18: Suppl. 33, 84s Year: 2001 Correlations between lung function characteristics and nocturnal oxygen saturation in severe COPD patients with normal body composition Source: Eur Respir J 2001; 18: Suppl. 33, 93s Year: 2001 Reversibility of diffusion capacity abnormalities in patients with clinical hypothyroidism with establishment of euthyroid state Source: Annual Congress 2013 –New issues in lung function testing Year: 2013 Decreased diffusion capacity in patients with diabetes microangiopathy Source: Eur Respir J 2006; 28: Suppl. 50, 655s Year: 2006 Total lung capacity % predicted explains reduced maximum aerobic capacity in patients with limited systemic sclerosis Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Undiagnosed heart failure in elderly COPD patients does not affect the diffusion capacity Source: Annual Congress 2008 - Lung function in respiratory disease Year: 2008 Histopathology of idiopathic pulmonary arterial hypertension in patients with low or normal diffusion capacity Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012 Baseline characteristics and survival of patients with idiopathic pulmonary fibrosis (IPF): analysis from the Swedish IPF registry Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020 Peak oxygen consumption is reduced in patients with sarcoidosis and is associated with the diffusion capacity of the lung and the left ventricular function Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease Year: 2009 Evaluation for patients‘ characteristics and related factors correlated with subclinical peripheral nerves deficit in stable COPD patients Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Stability or improvement in forced vital capacity with nintedanib in patients with idiopathic pulmonary fibrosis Source: Eur Respir J, 52 (2) 1702593; 10.1183/13993003.02593-2017 Year: 2018 Association between diffusion capacity and endothelial function in patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – Sarcoidosis, interstitial lung diseases and various clinical problems Year: 2018 Early decrease of forced vital capacity is a good prediction tool for prognosis in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008